A. Yu

Haemostatic complications in haemodialysis patients: effect of type of vascular access and dialysis filter

S. Jacobson, A. Yu, N. Egberg, 2003, Scandinavian journal of clinical and laboratory investigation.

Markers of inflammation and hypercoagulability in diabetic and nondiabetic patients with lower extremity ischemia.

J. Swedenborg, A. Yu, Marianne Thor, 2002, Thrombosis research.

False Increase in Serum C-Reactive Protein Caused by Monoclonal IgM-λ: a Case Report

A. Yu, U. Pira, 2001 .

Are Results of Fibrinogen Measurements Transferable?

M. Blombäck, A. Yu, N. Egberg, 2003, Clinical chemistry and laboratory medicine.

TheCoxProtein Isa Modulator ofDirectionality in Bacteriophage P2Site-Specific Recombination

A. Yu, Elisabeth HAGGARD-LJUNGQUISTt, 1993 .

Identification of amino acids in antiplasmin involved in its noncovalent 'lysine-binding-site'-dependent interaction with plasmin.

B. Wiman, A. Yu, Haiyao Wang, 2003, European journal of biochemistry.

The Presence of Heparin-Platelet Factor 4 Antibodies as a Marker of Hypercoagulability during Hemodialysis

S. Jacobson, A. Yu, N. Egberg, 2002, Clinical chemistry and laboratory medicine.

Purification and characterization of a cytosolic phosphoinositide-phospholipase C (gamma 2-type) from human platelets.

T. Takenawa, Y. Banno, Y. Nozawa, 1990, Biochemical and biophysical research communications.